Lorenzo Tallarigo, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 2,000 shares at $242.11 ($486K) on 2014-07-07, disclosed to the SEC on 2014-07-09.
Scheduled sale ($486k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $242.11 | 1,000 | $242K | 49.8% |
| 2 | $244.00 | 1,000 | $244K | 50.2% |
| Total | $243.06 avg | 2,000 | $486K | 100% |
| Filing → |
| ICPT | SELL | 2014-02-11 | $130K | — | Filing → |
| ICPT | SELL | 2014-01-09 | $124K | — | Filing → |
| ICPT | SELL | 2013-10-23 | $7.8M | — | Filing → |